Skip to main content
Signal8

Harler Mary Beth

SEC insider (Form 3/4/5 filer). CIK 0002018699. Chief Executive Officer at IGM Biosciences, Inc. (IGMS). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2025. Located in MOUNTAIN VIEW, CA.

Companies Harler Mary Beth has filed insider reports for

  • IGM Biosciences, Inc. (IGMS): Director, Officer, Chief Executive Officer
Harler Mary Beth profile photo

Harler Mary Beth

CIK: 0002018699

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IGM Biosciences, Inc. logo
IGMS

IGM Biosciences, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Aug 14, 2025
    Disposition
    Direct
    323.7K shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Jul 23, 2025
    Sale
    Direct
    14.5K shares at avg. $1.27$18K
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Jun 16, 2025
    Sale
    Direct
    1.5K shares at avg. $1.20$2K
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Mar 14, 2025
    Sale
    Direct
    7.3K shares at avg. $1.23$9K
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Dec 16, 2024
    Sale
    Direct
    1.7K shares at avg. $7.48$13K
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Oct 2, 2024
    Award
    Direct
    185K shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Sep 13, 2024
    Sale
    Direct
    1.5K shares at avg. $11.54$17K

1-7 of 7